Kazakhstan vs Marshall Islands: Leprosy - New leprosy cases with G2D rate per 1 000 000 population
Kazakhstan
0
in 2024
Marshall Islands
0
in 2024
Kazakhstan rank
86th
Marshall Islands rank
86th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population over time
- Kazakhstan
- Marshall Islands
How they compare
Kazakhstan currently reports 0 against 0 in Marshall Islands, a difference of 0.
The two have swapped places 2 times across 6 shared years of data; in 2016 it was Marshall Islands ahead.
Kazakhstan ranks 86th and Marshall Islands ranks 86th of 161 countries.
Kazakhstan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kazakhstan | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0183 | 0 | 0.0183 | Kazakhstan |
| 2020s | 0 | 0 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher leprosy - new leprosy cases with g2d rate per 1 000 000 population, Kazakhstan or Marshall Islands?
- Kazakhstan, at 0 against 0 in Marshall Islands as of 2024.
- What is the difference in leprosy - new leprosy cases with g2d rate per 1 000 000 population between Kazakhstan and Marshall Islands?
- 0, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Marshall Islands?
- 6 years are reported by both, from 2016 to 2024.
- How do Kazakhstan and Marshall Islands rank globally for leprosy - new leprosy cases with g2d rate per 1 000 000 population?
- Kazakhstan ranks 86th and Marshall Islands ranks 86th of 161 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Leprosy - New leprosy cases with G2D rate per 1 000 000 population. Statizoid refreshes it automatically from the source and publishes the full history for both places.